London Daily

Focus on the big picture.
Thursday, Sep 18, 2025

Even more evidence shows vaccinated people are unlikely to transmit the coronavirus or get asymptomatic infections

Even more evidence shows vaccinated people are unlikely to transmit the coronavirus or get asymptomatic infections

A new study shows that Pfizer's shot prevents asymptomatic infections almost as well as symptomatic cases of COVID-19.

Once effective coronavirus vaccines were authorized and started getting distributed, the crucial question became: Do they stop transmission?

In clinical trials, Pfizer and Moderna showed that their shots prevent symptomatic COVID-19, but they didn't test whether their vaccines prevent asymptomatic cases. Without curtailing symptom-less infections, it's difficult to stop transmission from person to person. But a growing body of evidence suggests that people who get these vaccines don't spread the virus after all.

Pfizer announced Thursday that its vaccine appears to be 94% effective at preventing asymptomatic infections two weeks after people receive their second dose. The study compared unvaccinated people in Israel to those who got the Pfizer shot between January 17 and March 6.

The findings are "particularly meaningful as we look to disrupt the spread of the virus around the globe," Dr. Luis Jodar, Pfizer's chief medical officer, said in a press release.

Vaccinated people may be less contagious if they get infected
People on the London Underground on September 25, 2020.

Research shows the more viral particles a person has in their mouth and nose — what's known as viral load — the more likely they are to pass the coronavirus to others. Reduced viral loads are linked to lower transmission rates.

So a vaccine should reduce transmission if it can ensure that even those who still get the coronavirus after their shots, whether a symptomatic or asymptomatic case, have a lower viral load than they would otherwise.

A February study from Israel, which has yet to be peer-reviewed, found that starting 12 days after vaccination, the people who got COVID-19 despite getting Pfizer's shots had four times less virus in their bodies.

The researchers looked at more than 1,000 people who'd tested positive for the virus after being fully vaccinated in Tel Aviv. Those people's viral loads in the period from 12 to 28 days after their second dose were four times lower than their viral loads in the first 11 days after vaccination.

Another study from Israel, also not yet peer-reviewed, suggested the Pfizer vaccine reduced viral loads by a factor of up to 20.

Some research suggests viral loads are linked to disease severity, so a patient with a lower viral load is also less likely to have severe COVID-19. That may in part explain why Pfizer's vaccine significantly reduces the chance of symptomatic infection.

Vaccinated people are less likely to develop asymptomatic infections
Dr. Jason Smith shows off his bandage after getting vaccinated at the University of Louisville Hospital in Kentucky.


To pinpoint whether vaccines truly reduce spread, it's critical to determine whether the shots prevent asymptomatic COVID-19 cases in addition to symptomatic infections.

Pfizer and Moderna's clinical trials only tested volunteers for COVID-19 if they felt ill. Otherwise, the companies would have had to require regular COVID-19 testing for all tens of thousands of volunteers. So at first, neither company could say whether their vaccines prevent asymptomatic cases.

But Moderna did test trial volunteers on the day they got their second shots. And the findings suggested that there were fewer asymptomatic infections among participants who'd received the real vaccine than among those who got a placebo. Just 14 people of the 14,000-plus in the trial's vaccine group had asymptomatic cases that day, compared to 38 of the similarly sized placebo group.

That's a 61.5% drop, according to Marm Kilpatrick, a disease ecologist at the University of California, Santa Cruz. He wrote on Twitter last month that the data suggests Moderna's vaccine blocks about 91% of transmission.

A man receives a COVID-19 vaccine at a health services center in Rehovot, Israel, on January 14, 2021.


Animal studies offer similar findings: An October paper found that the Moderna vaccine prevented the coronavirus from replicating in the nose, throat, and lungs of rhesus macaques four weeks after they'd been vaccinated. If the viral particles can't copy themselves, it's unlikely an infected host will pass on particles to others.

Before the Pfizer findings announced Thursday, a preliminary study published in The Lancet found the shot to be at least 85% effective at preventing any type of infection — symptomatic or asymptomatic. That study looked at more than 23,000 healthcare workers across hospitals in the UK.

Additionally, a recent study found that people who'd received at least one dose of a mRNA vaccine — from either Pfizer or Moderna — were 72% less likely to test positive for an asymptomatic infection 10 days after their shot, relative to unvaccinated people. The research looked at more than 39,000 Americans.

Johnson & Johnson's trial data on asymptomatic infections also seems promising. The company tested blood samples from almost 3,000 participants for coronavirus antibodies 71 days after they'd been vaccinated. (The presence of antibodies suggests participants had been infected even if they didn't show symptoms.) Only two vaccinated people tested positive, whereas 16 people who'd received a placebo did, according to data released last month from the Food and Drug Administration.

That suggests J&J's vaccine may be 74% effective against asymptomatic infections, though the FDA noted that more data is needed to be sure.

Vials of the Pfizer-BioNTech COVID-19 vaccines at Renown Health in Reno, Nevada on December 17, 2020.


Even the Oxford-AstraZeneca vaccine, which is still in clinical trials in the US, may reduce asymptomatic infections.

A February Oxford study, which has yet to be peer reviewed, found that among people who received just one dose, the number of positive COVID-19 tests — among both symptomatic and asymptomatic study participants — fell by 67%.

Comments

Oh ya 5 year ago
Go to Pfizer website and have a read. They do not even call this so called vaccine a vaccine. Wait 6 to 12 months and see what happens to those who took the vaccination

Newsletter

Related Articles

0:00
0:00
Close
US Tech Giants Pledge Billions to UK AI Infrastructure Following Starmer's Call
Saudi Arabia cracks down on music ‘lounges’ after conservative backlash
DeepMind and OpenAI Achieve Gold at ‘Coding Olympics’ in AI Milestone
SEC Allows Public Companies to Block Investors from Class-Action Lawsuits
Saudi Arabia Signs ‘Strategic Mutual Defence’ Pact with Pakistan, Marking First Arab State to Gain Indirect Access to Nuclear Strike Capabilities in the Region
Federal Reserve Cuts Rates by Quarter Point and Signals More to Come
Effective and Impressive Generation Z Protest: Images from the Riots in Nepal
European manufacturers against ban on polluting cars: "The industry may collapse"
Sam Altman sells the 'Wedding Estate' in Hawaii for 49 million dollars
Trump: Cancel quarterly company reports and settle for reporting once every six months
Turkish car manufacturer Togg Enters German Market with 5-Star Electric Sedan and SUV to Challenge European EV Brands
US Launches New Pilot Program to Accelerate eVTOL Air Taxi Deployment
Christian Brueckner Released from German Prison after Serving Unrelated Sentence
World’s Longest Direct Flight China Eastern to Launch 29-Hour Shanghai–Buenos Aires Direct Flight via Auckland in December
New OpenAI Study Finds Majority of ChatGPT Use Is Personal, Not Professional
Hong Kong Industry Group Calls for HK$20 Billion Support Fund to Ease Property Market Stress
Joe Biden’s Post-Presidency Speaking Fees Face Weak Demand amid Corporate Reluctance
Charlie Kirk's murder will break the left's hateful cancel tactics
Kash Patel erupts at ‘buffoon’ Sen. Adam Schiff over Russiagate: ‘You are the biggest fraud’
Homeland Security says Emmy speech ‘fanning the flames of hatred’ after Einbinder’s ‘F— ICE’ remark
Charlie Kirk’s Alleged Assassin Tyler Robinson Faces Death Penalty as Charges Formally Announced
Actor, director, environmentalist Robert Redford dies at 89
The conservative right spreads westward: a huge achievement for 'Alternative for Germany' in local elections
JD Vance Says There Is “No Unity” with Those Who Celebrate Charlie Kirk’s Killing, and he is right!
Trump sues the 'New York Times' for an astronomical sum of 15 billion dollars
Florida Hospital Welcomes Its Largest-Ever Baby: Annan, Nearly Fourteen Pounds at Birth
U.S. and Britain Poised to Finalize Over $10 Billion in High-Tech, Nuclear and Defense Deals During Trump State Visit
China Finds Nvidia Violated Antitrust Laws in Mellanox Deal, Deepens Trade Tensions with US
US Air Force Begins Modifications on Qatar-Donated Jet Amid Plans to Use It as Air Force One
Pope Leo Warns of Societal Crisis Over Mega-CEO Pay, Citing Tesla’s Proposed Trillion-Dollar Package
Poland Green-Lights NATO Deployment in Response to Major Russian Drone Incursion
Elon Musk Retakes Lead as World’s Richest After Brief Ellison Surge
U.S. and China Agree on Framework to Shift TikTok to American Ownership
London Daily Podcast: London Massive Pro Democracy Rally, Musk Support, UK Economic Data and Premier League Results Mark Eventful Weekend
This Week in AI: Meta’s Superintelligence Push, xAI’s Ten Billion-Dollar Raise, Genesis AI’s Robotics Ambitions, Microsoft Restructuring, Amazon’s Million-Robot Milestone, and Google’s AlphaGenome Update
Le Pen Tightens the Pressure on Macron as France Edges Toward Political Breakdown
Musk calls for new UK government at huge pro-democracy rally in London, but Britons have been brainwashed to obey instead of fighting for their human rights
Elon Musk responds to post calling for the murder of Erika Kirk, widow of Charlie Kirk: 'Either we fight back or they will kill us'
Czech Republic signs €1.34 billion contract for Leopard 2A8 main battle tanks with delivery from 2028
USA: Office Depot Employees Refused to Print Poster in Memory of Charlie Kirk – and Were Fired
Proposed U.S. Bill Would Allow Civil Suits Against Judges Who Release Repeat Violent Offenders
Penske Media Sues Google Over “AI Overviews,” Claiming It Uses Journalism Without Consent and Destroys Traffic
Indian Student Engineers Propose “Project REBIRTH” to Protect Aircraft from Crashes Using AI, Airbags and Smart Materials
French Debt Downgrade Piles Pressure on Macron’s New Prime Minister
US and UK Near Tech, Nuclear and Whisky Deals Ahead of Trump Trip
One in Three Europeans Now Uses TikTok, According to the Chinese Tech Giant
Could AI Nursing Robots Help Healthcare Staffing Shortages?
NATO Deploys ‘Eastern Sentry’ After Russian Drones Violate Polish Airspace
Anesthesiologist Left Operation Mid-Surgery to Have Sex with Nurse
Tens of Thousands of Young Chinese Get Up Every Morning and Go to Work Where They Do Nothing
×